Impaired feedback regulation of the receptor activity and the myofilament Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage

Journal of Cerebral Blood Flow and Metabolism

Volumn 30, Issue 9, 2010, Pages 1637-1650

  Kikkawa, Yuichiro ^a   Kameda, Katsuharu ^a   Hirano, Mayumi ^a   Sasaki, Tomio ^a   Hirano, Katsuya ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Ca2+ sensitivity; cerebral vasospasm; receptors; smooth muscle; subarachnoid hemorrhage

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOXIN; CALCIUM ION; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MYOSIN LIGHT CHAIN; PHENYLEPHRINE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR; TRYPSIN; UNCLASSIFIED DRUG; YM 254890; CALCIUM; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BLOOD VESSEL REACTIVITY; BRAIN VASOSPASM; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CALCIUM SIGNALING; CONTROLLED STUDY; CYTOSOL; EXPERIMENTAL RABBIT; IMMUNOBLOTTING; MALE; MYOFILAMENT; NEGATIVE FEEDBACK; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTION; SUBARACHNOID HEMORRHAGE; TACHYPHYLAXIS; VASODILATATION; ACTIN FILAMENT; ANIMAL; DRUG EFFECTS; FEEDBACK SYSTEM; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ACTIN CYTOSKELETON; ANIMALS; BASILAR ARTERY; CALCIUM; CYTOSOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEEDBACK, PHYSIOLOGICAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; PHENYLEPHRINE; PHOSPHORYLATION; RABBITS; RECEPTOR, PAR-1; RECEPTORS, ADRENERGIC, ALPHA-1; SUBARACHNOID HEMORRHAGE; TACHYPHYLAXIS; THROMBIN; VASOCONSTRICTOR AGENTS;

EID: 77956246218     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.35     Document Type: Article

References (39)

1. Abe Y, Nakayama K, Yamanaka A, Sakurai T, Goto K (2000) Subtype-specific trafficking of endothelin receptors. J Biol Chem 275:8664-8671
2. Booden M.A., Eckert LB, Der CJ, Trejo J (2004) Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion. Mol Cell Biol 24:1990-9
3. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, Piascik MT (2002) Differences in the cellular localization and agonist-mediated internalization properties of the a1-adrenoceptor subtypes. Mol Pharmacol 61:1008-16
4. Chen X, Earley K, Luo W, Lin SH, Schilling WP (1996) Functional expression of a human thrombin receptor in Sf9 insect cells: evidence for an active tethered ligand. Biochem J 314:603-611
5. Cockcroft S, Gomperts BD (1985) Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature 314:534-536
6. Drake MT, Shenoy SK, Lefkowitz RJ (2006) Trafficking of G protein-coupled receptors. Circ Res 99:570-582
7. Endo K, Matsumoto T, Kobayashi T, Kasuya Y, Kamata K (2005) Diabetes-related changes in contractile responses of stomach fundus to endothelin-1 in streptozotocininduced diabetic rats. J Smooth Muscle Res 41:35-47
8. Ferguson SS (2001) Evolving concepts in G proteincoupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1-24
9. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ (1997) Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity. J Biol Chem 272:17734-17743
10. Gilman AG (1984) G proteins and dual control of adenylate cyclase. Cell 36:577-579
11. Gong MC, Fujihara H, Walker LA, Somlyo AV, Somlyo AP (1997) Down-regulation of G-protein-mediated Ca2+ sensitization in smooth muscle. Mol Biol Cell 8:279-286
12. Hansen-Schwartz J, Hoel NL, Xu CB, Svendgaard NA, Edvinsson L (2003) Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in rats. J Neurosurg 99:115-120
13. Hinton M, Gutsol A, Dakshinamurti S (2007) Thromboxane hypersensitivity in hypoxic pulmonary artery myocytes: altered TP receptor localization and kinetics. Am J Physiol Lung Cell Mol Physiol 292:L654-63
14. Hirano K (2007) Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci 104:109-115
15. Holinstat M, Preininger AM, Milne SB, Hudson WJ, Brown HA, Hamm HE (2009) Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates. Mol Pharmacol 76:301-313
16. Hollenberg MD, Compton SJ (2002) Proteinase-activated receptors. Pharmacol Rev 54:203-217
17. Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K (1989) The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res 11:101-104
18. Itoh S, Sasaki T, Asai A, Kuchino Y (1994) Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 81:759-764
19. Kai Y, Hirano K, Maeda Y, Nishimura J, Sasaki T, Kanaide H (2007) Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke 38:3259-3265
20. Kai Y, Maeda Y, Sasaki T, Kanaide H, Hirano K (2008) Basic and translational research on proteinase-activated receptors: the role of thrombin receptor in cerebral vasospasm in subarachnoid hemorrhage. J Pharmacol Sci 108:426-432
21. Kassell NF, Sasaki T, Colohan AR, Nazar G (1985) Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572
22. Laher I, Zhang JH (2001) Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 21:887-906
23. Lurie KG, Tsujimoto G, Hoffman BB (1985) Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction. J Pharmacol Exp Ther 234: 147-152
24. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001) Proteinase-activated receptors. Pharmacol Rev 53:245-282
25. Maeda Y, Hirano K, Hirano M, Kikkawa Y, Kameda K, Sasaki T, Kanaide H (2009) Enhanced contractile response of the basilar artery to platelet-derived growth factor in subarachnoid hemorrhage. Stroke 40:591-596
26. Maeda Y, Hirano K, Kai Y, Hirano M, Suzuki SO, Sasaki T, Kanaide H (2007) Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage. Br J Pharmacol 152:1131-1139
27. Maeda Y, Hirano K, Nishimura J, Sasaki T, Kanaide H (2003) Rho-kinase inhibitor inhibits both myosin phosphorylation-dependent and -independent enhancement of myofilament Ca2+ sensitivity in the bovine middle cerebral artery. Br J Pharmacol 140:871-880
28. Miasiro N, Paiva AC (1990) Homologous desensitization of the effects of endothelin on rabbit aorta rings and on cultured rat aorta smooth muscle cells. Eur J Pharmacol 179:151-158
29. Miyagi Y, Carpenter RC, Meguro T, Parent AD, Zhang JH (2000) Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg 93:471-476
30. Moore CA, Milano SK, Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69:451-482
31. Nakayama T, Hirano K, Hirano M, Nishimura J, Kuga H, Nakamura K, Takahashi S, Kanaide H (2004) Inactivation of protease-activated receptor-1 by proteolytic removal of the ligand region in vascular endothelial cells. Biochem Pharmacol 68:23-32
32. Nakayama T, Hirano K, Shintani Y, Nishimura J, Nakatsuka A, Kuga H, Takahashi S, Kanaide H (2003) Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells. Br J Pharmacol 138:121-130
33. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M (1985) Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg 63:433-440
34. Sasaki T, Kassell NF, Zuccarello M, Nakagomi T, Fijiwara S, Colohan AR, Lehman M (1986) Barrier disruption in the major cerebral arteries during the acute stage after experimental subarachnoid hemorrhage. Neurosurgery 19:177-184
35. Sato M, Tani E, Fujikawa H, Kaibuchi K (2000) Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195-200
36. Takeya K, Loutzenhiser K, Shiraishi M, Loutzenhiser R, Walsh MP (2008) A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles. Am J Physiol Renal Physiol 294:F1487-92
37. Trejo J (2003) Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther 307:437-442
38. Vatter H, Konczalla J, Weidauer S, Preibisch C, Zimmermann M, Raabe A, Seifert V (2007) Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function. J Neurosurg 107:121-127
39. White RP, Robertson JT (1987) Pharmacodynamic evaluation of human cerebral arteries in the genesis of vasospasm. Neurosurgery 21:523-531